CYDNEE PARRIS: Open Payments
NPI 1881336410 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 22 payments from 11 companies in 2025. Trend: 2023 $480 · 2024 $517 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $101 |
| Baxter Healthcare | 4 | $84 |
| United Therapeutics Corporation | 3 | $63 |
| Insmed, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| Grifols USA, LLC | 1 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
Products named: NUCALA, Hillrom - Vest System Model 105 Home Care, Tyvaso, Arikayce, ARALAST, Prolastin-C Liquid, Cresemba, WINREVAIR.
Industry payments across TX — which companies pay providers there.
